Taylor-Weiner A, Aguet F, Haradhvala NJ, et al. Scaling computational genomics to millions of individuals with GPUs. Genome Biol. 2019;20(1):228. doi:10.1186/s13059-019-1836-7PubMedDOIGoogle Scholar
Cancer
Leong KW, Yu F, Adalsteinsson VA, et al. A nuclease-polymerase chain reaction enables amplification of probes used for capture-based DNA target enrichment. Nucleic Acids Res. 2019. doi:10.1093/nar/gkz870PubMedDOIGoogle Scholar
Hess JM, Bernards A, Kim J, et al. Passenger Hotspot Mutations in Cancer. Cancer Cell. 2019;36(3):288-301.e14. doi:10.1016/j.ccell.2019.08.002PubMedDOIGoogle Scholar
Parikh AR, Leshchiner I, Elagina L, et al. Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers. Nat Med. 2019;25(9):1415-1421. doi:10.1038/s41591-019-0561-9PubMedDOIGoogle Scholar
Van Allen EM. Finding the edge of the seat. Nat Med. 2019;25(9):1328. doi:10.1038/s41591-019-0557-5PubMedDOIGoogle Scholar
Sperling AS, Ebert BL. CHIPing away at breast cancer. J Natl Cancer Inst. 2019. doi:10.1093/jnci/djz158PubMedDOIGoogle Scholar
Reitman ZJ, Paolella BR, Bergthold G, et al. Mitogenic and progenitor gene programmes in single pilocytic astrocytoma cells. Nat Commun. 2019;10(1):3731. doi:10.1038/s41467-019-11493-2PubMedDOIGoogle Scholar
Boettcher S, Miller PG, Sharma R, et al. A dominant-negative effect drives selection of missense mutations in myeloid malignancies. Science. 2019;365(6453):599-604. doi:10.1126/science.aax3649PubMedDOIGoogle Scholar
Sethi N, Kikuchi O, McFarland J, et al. Mutant p53 induces a hypoxia transcriptional program in gastric and esophageal adenocarcinoma. JCI Insight. 2019;4(15). doi:10.1172/jci.insight.128439PubMedDOIGoogle Scholar
Wang SS, Bandopadhayay P, Jenkins MR. Towards Immunotherapy for Pediatric Brain Tumors. Trends Immunol. 2019;40(8):748-761. doi:10.1016/j.it.2019.05.009PubMedDOIGoogle Scholar